In a filing, Ionis Pharmaceuticals Inc revealed its Officer Schneider Eugene acquired Company’s shares for reported $56100.0 on Jan 31 ’25. In the deal valued at $33.00 per share,1,700 shares were bought.
Then, Geary Richard S bought 1,910 shares, generating $66,850 in total proceeds.
Before that, Swayze Eric bought 1,857 shares. Ionis Pharmaceuticals Inc shares valued at $64,995 were divested by the Officer at a price of $35.00 per share.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Friday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -4.26% to $31.90. Over the last five days, the stock has lost -8.20%. Ionis Pharmaceuticals Inc shares have fallen nearly -8.75% since the year began. Nevertheless, the stocks have fallen -38.54% over the past one year. While a 52-week high of $52.49 was reached on 01/02/25, a 52-week low of $31.40 was recorded on 01/17/25. SMA at 50 days reached $35.10, while 200 days put it at $40.77.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 31.22, which if violated will result in even more drops to 30.53. On the upside, there is a resistance level at 33.18. A further resistance level may holdings at 34.45. The Relative Strength Index (RSI) on the 14-day chart is 39.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.41%. Stochastics %K at 32.75% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-01-15, dropping by -0.29 million shares to a total of 10.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 10.53 million shares. There was a decline of -2.82%, which implies that there is a negative sentiment for the stock.
